{
  "ticker": "LLY",
  "target_date": "2025-11-05",
  "actual_date": "2025-11-05",
  "collected_at": "2025-12-08T12:29:42.970419",
  "price": {
    "open": 909.66,
    "high": 954.06,
    "low": 906.53,
    "close": 924.4523315429688,
    "volume": 7272900,
    "change_1d_pct": 2.09,
    "change_7d_pct": 12.03,
    "change_30d_pct": 24.8
  },
  "technicals": {
    "rsi_14": 78.91,
    "sma_20": 835.44,
    "sma_50": 791.05,
    "macd": 29.025,
    "macd_signal": 20.807,
    "macd_histogram": 8.218,
    "bb_upper": 906.44,
    "bb_lower": 764.44,
    "price_vs_sma20_pct": 10.65,
    "price_vs_sma50_pct": 16.86,
    "volume_ratio": 2.1
  },
  "fundamentals": {
    "market_cap": 892754395136,
    "pe_ratio": 48.79324,
    "forward_pe": 43.948368,
    "price_to_book": 37.495106,
    "price_to_sales": 15.024528,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.44,
    "pct_from_52w_low": 59.65
  },
  "macro": {
    "spy": {
      "price": 677.58,
      "change_1d_pct": 0.35,
      "change_7d_pct": -1.38
    },
    "vix": {
      "level": 18.01,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.16
    },
    "dollar_index": {
      "level": 100.2
    },
    "gold": {
      "price": 3980.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman",
      "source": "CNBC",
      "datetime": 1762364805,
      "summary": "Evan David Seigerman, BMO, joins 'Fast Money' to talk bidding wars in the pharma space, Novo Nordisk dropping on earnings, and more.",
      "url": "https://finnhub.io/api/news?id=cfe9e47ee98de69e7cbb68bef63f9652901488007daf65480cea18dcab0efd17"
    },
    {
      "headline": "Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled",
      "source": "DowJones",
      "datetime": 1762360279,
      "summary": "Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled",
      "url": "https://finnhub.io/api/news?id=61d5dedb015120793ddef7147290481373972ce714d8db774bca46b15555077a"
    },
    {
      "headline": "Novo Nordisk: Problems Compound, But Stock Still Cheap (Rating Downgrade)",
      "source": "SeekingAlpha",
      "datetime": 1762357240,
      "summary": "Novo Nordisk A/S downgraded after Q3 earnings and weight loss sector risks. Explore valuation, partnerships, and market outlook. Read why NVO stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=803b2900359a74b0957a3e5e4a799255f77cb3a1e40774680133b3d69a5d0d85"
    },
    {
      "headline": "Eli Lilly Stock Sees RS Rating Rise To 77",
      "source": "DowJones",
      "datetime": 1762350843,
      "summary": "Eli Lilly Stock Sees RS Rating Rise To 77",
      "url": "https://finnhub.io/api/news?id=11151af13b46ff3ceba4cba6b2f47ce6cb9f3f34b1ebeafaa8f8dae04a3d57ef"
    },
    {
      "headline": "Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears.",
      "source": "MarketWatch",
      "datetime": 1762339380,
      "summary": "Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears.",
      "url": "https://finnhub.io/api/news?id=226798083ac5988d0d3d3829e45b7420238eef9b69661adb7db375e2e7e69e1c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-05",
      "description": "xslF345X05/form4-11052025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000051/xslF345X05/form4-11052025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-04",
      "description": "xslF345X05/form4-11042025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000049/xslF345X05/form4-11042025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-03",
      "description": "xslF345X05/form4-11032025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000045/xslF345X05/form4-11032025_041101.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-30",
      "description": "lly-20250930.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/lly-20250930.htm"
    },
    {
      "form": "8-K",
      "date": "2025-10-30",
      "description": "lly-20251030.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000251/lly-20251030.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}